BioNTech SE
Biotechnology / ImmunotherapyFounded 2008- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
BioNTech SE
Annual Revenue
Last reviewed: 2025-07-15 · By Swet Parvadiya
FY2022 Revenue
$18.9B
BioNTech SE reported $18.9B in revenue for fiscal year 2022. In 2023, revenue declined to $4.2B.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.